While the concept of informed consent it a good one, there is a fundamental problem with the informed consent and how it is practiced today, writes Harlan Krumholz, MD, SM, professor of cardiology, epidemiology, and public health.
While the concept of informed consent it a good one, there is a fundamental problem with the informed consent and how it is practiced today, Harlan Krumholz, MD, SM, professor of cardiology, epidemiology, and public health at the Yale University School of Medicine and director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation, wrote in MedPage Today.
Ideally, through informed consent patients would learn about the risks and benefits of a treatment and alternatives, which could include doing nothing. Instead, the concept has "devolved into a perfunctory exercise by medical personnel to ensure that the 'chart' has the proper paperwork," he wrote.
Instead of being customized, consent forms are commonly standardized documents that require health literacy far exceeding the capability of th patient. In addition, they are often not well or rested enough to take the time to truly understand what is being presented to them.
Read the full article at MedPage Today: http://bit.ly/1Bu2MOD
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More